SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group
Main Authors: | Porksen, S, Laborie, L, Nielsen, L, De Wet, H, Schvarcz, E, Sandal, T, Aman, J, Swift, P, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Hansen, L, Njolstad, P, Mortensen, H |
---|---|
Format: | Conference item |
Published: |
2008
|
Similar Items
-
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
by: Pörksen, S, et al.
Published: (2010) -
Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
by: Tammaro, P, et al.
Published: (2005) -
Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
by: Proks, P, et al.
Published: (2006) -
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
by: Pearson, E, et al.
Published: (2006) -
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
by: Sagen, J, et al.
Published: (2004)